Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Receivables - Net (2022 - 2025)

Historic Receivables - Net for Coeptis Therapeutics Holdings (COEP) over the last 3 years, with Q3 2025 value amounting to $82500.0.

  • Coeptis Therapeutics Holdings' Receivables - Net changed N/A to $82500.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $82500.0, marking a year-over-year change of. This contributed to the annual value of $8075.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Receivables - Net of $82500.0 as of Q3 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Receivables - Net peaked at $461905.0 during Q2 2023, and registered a low of $8075.0 during Q4 2022.
  • In the last 3 years, Coeptis Therapeutics Holdings' Receivables - Net had a median value of $56250.0 in 2025 and averaged $145620.0.